As illustrated in Figure 5A, tumor volume and weight were slightly reduced by CM treatment, which was enhanced by KMT2D overexpression, and the anti-cancer effect was abolished by ITGAL deficiency. This evidence concerns the gene KMT2D and neoplasm.